Hermetica Superfood Encyclopedia
The Short Answer
Kaempferia parviflora rhizomes are rich in polymethoxyflavones—including 5,7,4'-trimethoxyflavone, 5,7,3',4'-tetramethoxyflavone, and pentamethylquercetin—that inhibit pro-inflammatory enzymes and modulate oxidative stress pathways at the molecular level. In vitro studies demonstrate antiplasmodial activity with IC50 values of 3.70–4.06 μg/ml for key trimethoxyflavones, antifungal effects against Candida albicans at IC50 17.63–39.71 μg/ml, and cytotoxicity against the SKBR-3 breast cancer cell line at IC50 11.79 μg/ml via essential oil fractions, though rigorous human clinical trial data remain limited.
CategoryRoot
GroupSoutheast Asian
Evidence LevelPreliminary
Primary KeywordKaempferia parviflora benefits
Black Ginger — botanical close-up
Health Benefits
**Anti-inflammatory Activity**
Polyphenol-rich extracts suppress UV-induced COX-2 expression and PGE2 production in HaCaT keratinocytes by inhibiting NF-κB and p-c-Jun (Ser73) transcriptional activation, reducing pro-inflammatory signaling cascades at concentrations of 100–400 μg/ml in vitro.
**Antioxidant Protection**
The essential oil exhibits free-radical scavenging capacity with DPPH IC50 of 0.50 mg/ml and ABTS IC50 of 0.40 mg/ml, attributable to monoterpene constituents including α-pinene, camphene, linalool, and camphor alongside polyphenols such as gallic acid (9.31 μg/mg dry weight).
**Antiplasmodial (Antimalarial) Effects**
The methoxyflavones 5,7,4'-trimethoxyflavone and 5,7,3',4'-tetramethoxyflavone demonstrate antiplasmodial activity against Plasmodium falciparum at IC50 values of 3.70 and 4.06 μg/ml respectively, without cytotoxicity to normal KB, BC, or NCI-H187 cell lines.
**Antifungal Properties**
3,5,7,4'-tetramethoxyflavone and 5,7,4'-trimethoxyflavone inhibit Candida albicans growth at IC50 values of 39.71 and 17.63 μg/ml respectively, suggesting utility as adjunctive antifungal agents particularly for superficial fungal infections.
**Anticancer Cytotoxicity**
Essential oil fractions exhibit selective cytotoxicity against cancer cell lines including SKBR-3 (breast cancer, IC50 11.79 μg/ml) and A549 (lung adenocarcinoma, IC50 38.73 μg/ml), with terpene and polymethoxyflavone constituents implicated as primary mediators.
**Antimycobacterial Activity**
Key trimethoxyflavones display activity against mycobacterial strains with MIC values of 50–200 μg/ml, providing a preliminary mechanistic rationale for traditional use against respiratory infections, though in vivo confirmation is lacking.
**Vitality and Aphrodisiac Support**
Traditional Thai medicine attributes aphrodisiac and energy-enhancing effects to rhizome preparations; preclinical data suggest polymethoxyflavones such as pentamethylquercetin and dimethoxyflavone may modulate phosphodiesterase activity and androgenic pathways, though controlled human studies are absent.
Origin & History
Natural habitat
Kaempferia parviflora is native to Thailand and neighboring regions of mainland Southeast Asia, where it grows as a perennial herb in tropical and subtropical forest understories at low to moderate elevations. The plant thrives in well-drained, loamy soils under partial shade with high humidity, conditions typical of the Zingiberaceae family. Rhizomes are harvested from cultivated and wild populations primarily in northern and northeastern Thailand, where the plant holds significant ethnobotanical importance.
“Kaempferia parviflora, locally known as 'Kra Chai Dam' (black galangal or black ginger) in Thailand, has been used for centuries in Thai traditional medicine as a tonic herb for male vitality, sexual performance, physical endurance, and inflammatory conditions including joint pain and gastrointestinal discomfort. The rhizome's distinctively dark purple-black interior has historically differentiated it from related species and contributed to its association with potent therapeutic properties in folk medicine systems of Thailand, Laos, and Myanmar. Preparations traditionally involved drying and powdering the rhizome for incorporation into herbal teas, rice wine infusions, and medicinal decoctions, with certain preparations historically administered to Thai warriors and traditional athletes to enhance stamina. The plant is listed as a traditional Thai medicinal herb and has attracted increasing scientific interest since the late 1990s as phytochemical tools advanced to characterize its unique polymethoxyflavone profile.”Traditional Medicine
Scientific Research
The current evidence base for Kaempferia parviflora is predominantly preclinical, comprising in vitro cell-line assays and essential oil characterization studies using GC-TOF-MS, with no large-scale randomized controlled trials identified in the peer-reviewed literature. In vitro studies have quantified IC50 values for antiplasmodial, antifungal, antioxidant, and cytotoxic endpoints, providing mechanistic direction but limited translational certainty due to the well-known discrepancy between in vitro concentrations and achievable in vivo plasma levels. GC-TOF-MS analysis has identified 129 compounds in the rhizome essential oil, providing robust phytochemical characterization, but pharmacokinetic studies defining bioavailability, metabolite profiles, and effective human dosing remain absent from the published literature. Overall, the evidence tier is preliminary, and while the phytochemical rationale is scientifically coherent, clinical efficacy and safety in humans cannot yet be confirmed without properly powered human trials.
Preparation & Dosage
Traditional preparation
**Dried Rhizome Powder (Traditional)**
1–3 g of dried rhizome per day, though this is not standardized by clinical trials
Typically prepared as a decoction or incorporated into food/drink; traditional Thai usage involves .
**Standardized Extract Capsules**
100–600 mg/day in supplement form; no clinical trial-validated dosing exists
Commercial products are often standardized to polymethoxyflavone content (e.g., 5,7,4'-trimethoxyflavone or total methoxyflavones), with dosages ranging from .
**Essential Oil**
Extracted via hydrodistillation from fresh or dried rhizomes; used primarily in research and topical applications; internal dosing guidelines are not established.
**Ethanolic or Aqueous Extract**
Used in preclinical studies at 100–400 μg/ml in vitro; no direct conversion to safe oral human doses has been validated.
**Timing**
No pharmacokinetic data exist to guide dosing timing; traditional use is typically with meals.
**Standardization Note**
Look for products specifying polymethoxyflavone content, particularly 5,7,4'-trimethoxyflavone or total methoxyflavones ≥5%; the absence of standardization guidelines underscores the need for caution.
Nutritional Profile
Kaempferia parviflora rhizomes are not a significant macronutrient source and are consumed in small quantities as a functional herb rather than a dietary staple. The dominant phytochemical classes are polymethoxyflavones—including dimethoxyflavone (DMF), trimethoxyflavone (TrMF), tetramethoxyflavone (TMF), and pentamethylquercetin (PMF)—alongside kaempferioside A and B glycosides and tectochrysin. Polyphenol analysis of extracts reveals gallic acid as the most abundant individual polyphenol at approximately 9.31 ± 1.27 μg/mg dry weight, followed by apigenin (2.37 μg/mg), tangeretin (2.15 μg/mg), naringenin (1.55 μg/mg), luteolin (1.00 μg/mg), caffeic acid (0.86 μg/mg), and protocatechuic acid (0.05 μg/mg). The essential oil fraction (129 identified compounds) contributes monoterpenes and sesquiterpenes including α-pinene, camphene, linalool, camphor, borneol, and α-copaene; bioavailability of methoxyflavones is likely enhanced by their lipophilic methoxy substitutions relative to hydroxylated parent flavonoids, but human pharmacokinetic data are not published.
How It Works
Mechanism of Action
The primary anti-inflammatory mechanism involves polymethoxyflavones and polyphenols suppressing UV-induced transcriptional upregulation of COX-2 by blocking NF-κB nuclear translocation and reducing phosphorylation of c-Jun at Ser73, thereby curtailing downstream PGE2 biosynthesis in human keratinocytes. Antioxidant activity is mediated through direct radical scavenging by gallic acid, apigenin, and terpenoid constituents of the essential oil (α-pinene, linalool, camphor), which donate hydrogen atoms to neutralize DPPH and ABTS radicals. Antiplasmodial and antifungal effects of 5,7,4'-trimethoxyflavone and related compounds likely result from disruption of parasite or fungal membrane integrity and interference with essential metabolic enzymes, a mechanism shared among polymethoxylated flavonoids. The proposed aphrodisiac and vitality-enhancing effects are hypothesized to involve inhibition of phosphodiesterase-5 (PDE-5) by dimethoxyflavone and tetramethoxyflavone, enhancing cyclic GMP signaling in smooth muscle, though direct receptor-binding data from human studies are not yet established.
Clinical Evidence
No peer-reviewed human clinical trials with defined sample sizes, randomization procedures, or reported effect sizes were identified for Kaempferia parviflora as of the current literature review. Available data derive exclusively from in vitro models (cell lines such as HaCaT, SKBR-3, A549, KB, BC, NCI-H187) and phytochemical characterization studies, which, while informative for mechanistic hypothesis generation, do not constitute clinical evidence of efficacy or safety in human populations. Outcome measures studied preclinically include IC50 for antioxidant, antiplasmodial, antifungal, and cytotoxic endpoints, as well as COX-2 and PGE2 suppression in keratinocyte models, but none of these have been validated in human subjects under controlled conditions. Confidence in clinical recommendations remains low, and practitioners should regard current findings as hypothesis-generating rather than practice-informing.
Safety & Interactions
Isolated polymethoxyflavones from Kaempferia parviflora did not exhibit cytotoxicity toward KB (oral cancer), BC (breast cancer), or NCI-H187 (small cell lung cancer) cell lines at tested concentrations in vitro, suggesting a favorable preliminary safety profile for the purified flavonoid fraction. However, no formal human safety studies, maximum tolerated dose trials, or documented adverse event profiles exist in the peer-reviewed literature, making definitive safety conclusions premature. Potential drug interactions have not been studied; given that methoxyflavones and flavonoids as a class can inhibit cytochrome P450 enzymes (particularly CYP1A2, CYP3A4), caution is theoretically warranted in individuals taking narrow-therapeutic-index medications metabolized by these pathways, including anticoagulants, immunosuppressants, and antiretrovirals. Contraindications in pregnancy and lactation have not been studied, and in the absence of safety data, use during pregnancy, lactation, or in pediatric populations should be avoided; individuals with hormone-sensitive conditions should consult a healthcare provider before use given the proposed androgenic and PDE-5 inhibitory mechanisms.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Kaempferia parviflora Wall. ex BakerKra Chai DamBlack GalangalThai Black GingerKrachai Dam
Frequently Asked Questions
What is Kaempferia parviflora used for?
Kaempferia parviflora (black ginger) is traditionally used in Thai medicine to support male vitality, aphrodisiac function, physical endurance, and relief from inflammation. Preclinical studies identify polymethoxyflavones—including 5,7,4'-trimethoxyflavone and pentamethylquercetin—as the primary bioactives responsible for anti-inflammatory, antioxidant, antiplasmodial, and antifungal effects observed in cell and tissue models, though human clinical validation is currently lacking.
What is the recommended dosage of Kaempferia parviflora?
No clinically validated dosing regimen for Kaempferia parviflora has been established through human trials. Traditional Thai use involves approximately 1–3 g of dried rhizome powder daily, while commercial standardized extracts are typically marketed at 100–600 mg/day with polymethoxyflavone content specifications; in vitro studies used crude extract concentrations of 100–400 μg/ml that do not directly translate to oral human doses.
Does Kaempferia parviflora have aphrodisiac effects?
Black ginger has a long traditional reputation as an aphrodisiac in Southeast Asian ethnomedicine, and preclinical research proposes that dimethoxyflavone and tetramethoxyflavone may inhibit phosphodiesterase-5 (PDE-5), thereby enhancing cyclic GMP signaling in smooth muscle tissue similarly to pharmaceutical PDE-5 inhibitors. However, no peer-reviewed human clinical trials have confirmed aphrodisiac efficacy, sexual performance outcomes, or hormonal effects in men or women, so these claims remain mechanistically plausible but clinically unverified.
Is Kaempferia parviflora safe to take?
In vitro studies show that isolated polymethoxyflavones from Kaempferia parviflora are non-cytotoxic to several human cancer and normal cell lines at tested concentrations, suggesting acceptable cellular tolerability for purified fractions. However, no human safety trials, toxicology studies, or documented adverse event reports are published, meaning formal safety conclusions cannot be drawn; potential inhibition of CYP450 enzymes (CYP1A2, CYP3A4) warrants caution with co-administered medications, and use during pregnancy or lactation is not recommended due to insufficient data.
What are the active compounds in Kaempferia parviflora?
The primary bioactive compounds in Kaempferia parviflora rhizomes are polymethoxyflavones—specifically dimethoxyflavone (DMF), trimethoxyflavone (TrMF), tetramethoxyflavone (TMF), pentamethylquercetin (PMF), and tetramethylkaempferol—alongside polyphenols including gallic acid (9.31 μg/mg dry weight), apigenin (2.37 μg/mg), and tangeretin (2.15 μg/mg). The essential oil fraction contributes 129 identified volatile compounds, with major constituents including camphene (up to 9.39%), α-pinene (7.50%), linalool (5.46%), and camphor (5.04%), which contribute to antioxidant and cytotoxic activities.
What is the evidence for Kaempferia parviflora's anti-inflammatory effects?
In vitro research demonstrates that polyphenol-rich extracts of Kaempferia parviflora suppress UV-induced inflammatory markers by inhibiting NF-κB and p-c-Jun signaling pathways in skin cells at concentrations of 100–400 μg/ml. These studies show reduced expression of COX-2 and PGE2 production, key mediators of inflammation. However, clinical human trials are limited, so more research is needed to establish effective dosing and therapeutic applications in vivo.
Does Kaempferia parviflora interact with blood thinners or cardiovascular medications?
While Kaempferia parviflora contains polyphenolic compounds with antioxidant properties that may theoretically affect platelet aggregation and blood flow, specific drug interaction studies with anticoagulants or cardiovascular drugs are not well documented in the scientific literature. Individuals taking warfarin, aspirin, or other blood-thinning medications should consult a healthcare provider before supplementing with this ingredient. The lack of robust interaction data makes precaution advisable for those on such medications.
What forms of Kaempferia parviflora are most commonly available and studied?
Kaempferia parviflora is typically available as dried root powder, standardized polyphenol extracts, and essential oil formulations. Most clinical and mechanistic research has focused on polyphenol-standardized extracts and essential oil preparations due to their concentrated bioactive compounds. Root powder forms may have variable potency depending on growing conditions and processing, while extracts provide more consistent dosing of active flavonoids and essential oil constituents.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w kaempferia-parviflora-kaempferia-parviflora-wall-ex-baker curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
